Cargando...

Ramucirumab for advanced gastric cancer or gastro-oesophageal junction adenocarcinoma

Ramucirumab, a fully humanized monoclonal antibody directed against vascular endothelial growth factor receptor 2, is the first targeted agent to have demonstrated an improvement in survival, as a single agent or in combination, in a molecularly unselected population in gastro-oesophageal cancer. No...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Therap Adv Gastroenterol
Autores principales: Young, Kate, Smyth, Elizabeth, Chau, Ian
Formato: Artigo
Lenguaje:Inglês
Publicado: SAGE Publications 2015
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4622287/
https://ncbi.nlm.nih.gov/pubmed/26557893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756283X15592586
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!